Cited by 39Chronic Kidney Disease and DiabetesMesenchymal stem cell researchAcute Kidney Injury Research

Healthy Bone Marrow Cells Reduce Progression of Kidney Failure Better than CKD Bone Marrow Cells in Rats with Established Chronic Kidney Disease

Open access
Van Koppen, Arianne, Joles, Jaap A., Bongartz, Lennart G., Van Den Brandt, Jens, Reichardt, Holger M., Goldschmeding, Roel, Nguyen, Tri Q., Verhaar, Marianne C.·2012·Cell Transplantation

Abstract

Chronic kidney disease (CKD) is a major health care problem. New interventions to slow or prevent disease progression are urgently needed. We studied functional and structural effects of infusion of healthy and CKD bone marrow cells (BMCs) in a rat model of established CKD. CKD was induced by 5/6 nephrectomy (SNX) in Lewis rats, and disease progression was accelerated with l-NNA and 6% NaCl diet. Six weeks after SNX, CKD rats received healthy eGFP + BMCs, CKD eGFP + BMCs, or vehicle by single renal artery injection. Healthy BMCs were functionally effective 6 weeks after administration: glomerular filtration rate (GFR; inulin clearance) (0.48 ± 0.16 vs. 0.26 ± 0.14 ml/min/100 g) and effective renal plasma flow (RPF; PAH clearance) (1.6 ± 0.40 vs. 1.0 ± 0.62 ml/min/100 g) were higher in healthy BMC-versus vehicle-treated rats (both p < 0.05). Systolic blood pressure (SBP) and proteinuria were lower 5 weeks after treatment with healthy BMCs versus vehicle (SBP, 151 ± 13 vs. 186 ± 25 mmHg; proteinuria, 33 ± 20 vs. 59 ± 39 mg/day, both p < 0.05). Glomerular capillary density was increased, and less sclerosis was detected after healthy BMCs (both p < 0.05). Tubulointerstitial inflammation was also decreased after healthy BMCs. eGFP + cells were present in the glomeruli and peritubular capillaries of the remnant kidney in all BMC-treated rats. CKD BMCs also reduced SBP, proteinuria, glomerulosclerosis, and tubular atrophy versus vehicle in CKD rats. However, CKD BMC therapy was not functionally effective versus vehicle [GFR: 0.28 ± 0.09 vs. 0.26 ± 0.16 ml/min/100 g (NS), RPF: 1.15 ± 0.36 vs. 0.78 ± 0.44 ml/min/100 g (NS)], and failed to decrease tubulointerstitial inflammation and fibrosis. Single intrarenal injection of healthy BMCs in rats with established CKD slowed progression of the disease, associated with increased glomerular capillary density and less sclerosis, whereas injection of CKD BMCs was less effective.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3727/096368912x636795

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Release of inflammatory immune cells from the bone marrow contributes to the pathogenesis of hypertension and chronic kidney disease.

    “and the release of these inflammatory immune cells from the bone marrow contributes to the pathogenesis of hypertension and CKD15,156,189.”
  • Abnormal sympathetic drive to the bone marrow in hypertension and chronic kidney disease dramatically shifts the immune properties of haematopoietic cells to a pro-inflammatory state.

    “Abnormal sympathetic drive to the bone marrow in hypertension and CKD dramatically shifts the immune properties of haematopoietic cells to a pro-inflammatory state”
  • The immune pathway of the brain-kidney axis involves input from the CNS and/or sympathetic nervous system to the bone marrow and effects of inflammatory cells released from the bone marrow on the kidney.

    “Therefore, the immune pathway of the brain-kidney axis involves input from the CNS and/or SNS to the bone marrow and the effects of inflammatory cells released from the bone marrow on the kidney.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Van Koppen, A., Joles, J. A., Bongartz, L. G., Van Den Brandt, J., Reichardt, H. M., Goldschmeding, R., Nguyen, T. Q., & Verhaar, M. C.
Affiliations
  • Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands
  • University Medical Center Utrecht (NL)
  • Department of Cellular and Molecular Immunology, University of Göttingen Medical School, Göttingen, Germany
  • Universitätsmedizin Göttingen (DE)
Corresponding author
Verhaar, Marianne C.
Venue
Cell Transplantation
Published
2012-10
Volume
21
Issue
10
Pages
2299-2312
ISSN
  • 0963-6897 (ISSN-L)
  • 1555-3892
OpenAlex
W2318903660
Cited by
39
References
55
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 6 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 7 · 2014: 4 · 2013: 3 · 2012: 1
FWCI
3.79
Type
journal article
Language
en
Locations
  • Cell Transplantation (publishedVersion)
  • PubMed (publishedVersion)
  • GRO (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
Funders
  • Nierstichting
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.096.359)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
chronic kidney disease, bone marrow cells, cell therapy, kidney failure progression, 5/6 nephrectomy, glomerular filtration rate, renal plasma flow, proteinuria, blood pressure, glomerulosclerosis, tubulointerstitial inflammation, renal fibrosis, tubular atrophy, remnant kidney, rat model, L-NNA
MeSH terms
Animals, Blood Pressure, Bone Marrow Cells, Disease Models, Animal, Kidney Glomerulus, Male, Rats, Inbred Lew, Bone Marrow Transplantation, Disease Progression, Rats, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review